Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury.

Carpenter TC, Schroeder W, Stenmark KR, Schmidt EP.

Am J Respir Cell Mol Biol. 2012 Jan;46(1):40-7. doi: 10.1165/rcmb.2011-0044OC.

2.

EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia.

Cercone MA, Schroeder W, Schomberg S, Carpenter TC.

Am J Physiol Lung Cell Mol Physiol. 2009 Nov;297(5):L856-63. doi: 10.1152/ajplung.00118.2009. Epub 2009 Aug 14.

3.

Endothelial EphA receptor stimulation increases lung vascular permeability.

Larson J, Schomberg S, Schroeder W, Carpenter TC.

Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L431-9. doi: 10.1152/ajplung.90256.2008. Epub 2008 Jul 3.

4.

Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury.

Hong JY, Shin MH, Douglas IS, Chung KS, Kim EY, Jung JY, Kang YA, Kim SK, Chang J, Kim YS, Park MS.

Clin Sci (Lond). 2016 Nov 1;130(21):1993-2003. Epub 2016 Aug 22.

PMID:
27549114
5.

Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.

Sukka-Ganesh B, Mohammed KA, Kaye F, Goldberg EP, Nasreen N.

BMC Cancer. 2012 Jul 23;12:309. doi: 10.1186/1471-2407-12-309.

6.

EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.

Brantley-Sieders DM, Caughron J, Hicks D, Pozzi A, Ruiz JC, Chen J.

J Cell Sci. 2004 Apr 15;117(Pt 10):2037-49. Epub 2004 Mar 30.

7.

Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.

Ferluga S, Hantgan R, Goldgur Y, Himanen JP, Nikolov DB, Debinski W.

J Biol Chem. 2013 Jun 21;288(25):18448-57. doi: 10.1074/jbc.M113.464008. Epub 2013 May 9.

8.

EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration.

Kaplan N, Fatima A, Peng H, Bryar PJ, Lavker RM, Getsios S.

Invest Ophthalmol Vis Sci. 2012 Feb 23;53(2):936-45. doi: 10.1167/iovs.11-8685. Print 2012 Feb.

9.

Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.

Guo H, Miao H, Gerber L, Singh J, Denning MF, Gilliam AC, Wang B.

Cancer Res. 2006 Jul 15;66(14):7050-8.

10.

ADAM12-cleaved ephrin-A1 contributes to lung metastasis.

Ieguchi K, Tomita T, Omori T, Komatsu A, Deguchi A, Masuda J, Duffy SL, Coulthard MG, Boyd A, Maru Y.

Oncogene. 2014 Apr 24;33(17):2179-90. doi: 10.1038/onc.2013.180. Epub 2013 May 20.

PMID:
23686306
11.

Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.

Ishikawa M, Miyahara R, Sonobe M, Horiuchi M, Mennju T, Nakayama E, Kobayashi M, Kikuchi R, Kitamura J, Imamura N, Huang CL, Date H.

Lung Cancer. 2012 Jun;76(3):431-8. doi: 10.1016/j.lungcan.2011.12.004. Epub 2012 Jan 10.

PMID:
22236865
13.

All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling.

Leem AY, Shin MH, Douglas IS, Song JH, Chung KS, Kim EY, Jung JY, Kang YA, Chang J, Kim YS, Park MS.

Biochem Biophys Res Commun. 2017 Sep 23;491(3):721-726. doi: 10.1016/j.bbrc.2017.07.122. Epub 2017 Jul 22.

PMID:
28743499
14.

The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.

Youngblood VM, Kim LC, Edwards DN, Hwang Y, Santapuram PR, Stirdivant SM, Lu P, Ye F, Brantley-Sieders DM, Chen J.

Cancer Res. 2016 Apr 1;76(7):1825-36. doi: 10.1158/0008-5472.CAN-15-0847. Epub 2016 Feb 1.

15.

EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis.

Funk SD, Yurdagul A Jr, Albert P, Traylor JG Jr, Jin L, Chen J, Orr AW.

Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):686-95. doi: 10.1161/ATVBAHA.111.242792. Epub 2012 Jan 12.

16.

Effect of ephrin-A1/EphA2 on invasion of trophoblastic cells.

Yang Y, Min J.

J Huazhong Univ Sci Technolog Med Sci. 2011 Dec;31(6):824-7. doi: 10.1007/s11596-011-0684-9. Epub 2011 Dec 16.

PMID:
22173506
17.

Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.

Efazat G, Novak M, Kaminskyy VO, De Petris L, Kanter L, Juntti T, Bergman P, Zhivotovsky B, Lewensohn R, Hååg P, Viktorsson K.

Oncotarget. 2016 Sep 13;7(37):60332-60347. doi: 10.18632/oncotarget.11219.

18.

The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.

Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman AL, Pasquale EB.

Oncogene. 2000 Dec 7;19(52):6043-52.

19.

Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.

Fang WB, Brantley-Sieders DM, Hwang Y, Ham AJ, Chen J.

J Biol Chem. 2008 Jun 6;283(23):16017-26. doi: 10.1074/jbc.M709934200. Epub 2008 Apr 3.

20.

Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.

Abraham S, Knapp DW, Cheng L, Snyder PW, Mittal SK, Bangari DS, Kinch M, Wu L, Dhariwal J, Mohammed SI.

Clin Cancer Res. 2006 Jan 15;12(2):353-60.

Supplemental Content

Support Center